Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-06-05
2007-06-05
Price, Elvis O. (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S938000, C424S450000, C424S455000, C546S169000
Reexamination Certificate
active
10424998
ABSTRACT:
Oral pharmaceutical formulation which improves the bioavailability of pharmaceuticals which are substantially water and oil insoluble is disclosed. In addition to the pharmaceutical, the formulation includes an emulsifier, an oil and an solubilizer. Alternatively, the formulation includes an aqueous solution of solubilizer.
REFERENCES:
patent: 4388307 (1983-06-01), Cavanak
patent: 4816247 (1989-03-01), Desai et al.
patent: 5206219 (1993-04-01), Desai
patent: 5258185 (1993-11-01), Bauer et al.
patent: 5342625 (1994-08-01), Hauer et al.
patent: 5403858 (1995-04-01), Bastard et al.
patent: 5482947 (1996-01-01), Talley et al.
patent: 5484801 (1996-01-01), Al-Razzak et al.
patent: 156 507 (1985-02-01), None
patent: 517 412 (1992-12-01), None
patent: 62250941 (1987-10-01), None
patent: WO 92/00750 (1992-01-01), None
patent: WO 95/07696 (1995-03-01), None
S. H. Yalkowsky,Drugs and the Pharmaceutical Sciences: Techniques of Solubilization of Drugs, Marcel Dekker, Inc., vol. 12, 1981, p. 1-224.
Charman et al., Pharm. Res., vol. 9, pp. 87-93, 1992.
Iranloye and Pilpel, J. Pharm. Sci., vol. 73, pp. 1267-1270, 1984.
Wakerly et al., J. Pharm. Pharmacol, vol. 3, suppl., 6P, 1987, p. 242.
Roberts et al., Science, vol. 248, pp. 358-361, 1990.
J.A. Martin, Drugs of the Future, vol. 16(3), pp. 210-212, 1991.
Kagayama et al., Antimicrobial Agents and Chemotherapy, pp. 810-817, 1993.
Lam et al., “De Novo Design and Discovery of Potent, Nonpeptidal HIV-1 Protease Inhibitors”, paper 96 at the 205thAmerican Chemical Society National Meeting, Medicinal Chemistry Division, Denver, CO, Mar. 28-Apr. 2, 1993, Abstract Only.
Dorsey et al., “L-735,524: The Rational Design of a Potent and Orally Bioavailable HIV Protease Inhibitor”, paper 6 at the 206thAmerican Chemical Society National Meeting, Medicinal Chemistry Division Chicago, IL Aug. 22-27, 1993, Abstract Only.
Wai et al., J. Med. Chem., vol. 36, pp. 249-255, 1993.
Provost et al., Acta Phar. Technol., vol. 35(3), pp. 143-148, 1989.
De Vos et al., J. Pharm. Sciences, vol. 83(5), pp. 641-643, 1994.
Getman et al., J. Med. Chem., “Discovery of a Novel Class of Potent HIV-1 Protease Inhibitors” vol. 36, pp. 288-291, 1993.
Shah et al., Int. Journal of Pharmaceutics, “Self-Emulsifying drug delivery systems (SEODS)” vol. 106, pp. 15-23, 1994.
Mueller et al., Pharm. Research, “Influence of a Fat-Rich Meal on the Pharmaco Kinetics”, vol. 11, No. 1, pp. 151-155, 1994.
Hoffman et al., J. Med. Chem, vol. 35, pp. 3784-3791, 1992.
Saari et al., J. Med. Chem., vol. 35, pp. 3792-3802, 1992.
Romero et al., J. Med. Chem. vol. 36, pp. 1505-1508, 1993.
Hargrave, J. Med. Chem., vol. 34, pp. 2231-2241, 1991.
Merluzzi, Science, vol. 250, pp. 1411-1413, 1990.
Williams et al., J. Med. Chem., vol. 36, pp. 1291-1294, 1993.
HSU et al., Proc. Natl. Acad. Sci. USA, vol. 909, pp. 6395-6399, 1993.
Tam et al., “Tat Inhibitors: A New Class Of Anti-HIV Agents” paper 372, at the 204thAmerican Chemical Society National Meeting, Organic Chemistry Division, Washington, DC, Aug. 23-28, 1992, Abstract Only.
Regdon et al., Pharm. Ind., vol. 46, Nr. 11, 1984, No Translation.
Dreyer et al., Biochemistry, “Hydroxyethylene Isostere Inhibitors of HIV-1 Protease”, vol. 31, pp. 6646-6659, 1992.
Charman,Pharmaceutical Research(New York) 9(1): p. 87-93 (1992).
Gokhale Rajeev
Griffin Martin J.
Karim Aziz
Roy Ajit K.
Stolzenbach James C.
Banner & Witcoff , Ltd.
G.D. Searle LLC
Price Elvis O.
LandOfFree
Self-emulsifying drug delivery system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Self-emulsifying drug delivery system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Self-emulsifying drug delivery system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3856536